Maternal microchimerism in the livers of patients with Biliary atresia by David L Suskind et al.
BioMed CentralBMC Gastroenterology
ssOpen AcceResearch article
Maternal microchimerism in the livers of patients with Biliary 
atresia
David L Suskind*, Philip Rosenthal1, Melvin B Heyman2, Denice Kong3, 
Greg Magrane1, Lee-Ann Baxter-Lowe2 and Marcus O Muench3
Address: 1Department of Pediatrics, University of California, San Francisco, USA, 2Immunogenetics, University of California, San Francisco, USA 
and 3Laboratory Medicine, University of California, San Francisco, USA
Email: David L Suskind* - david.suskind@seattlechildrens.org; Philip Rosenthal - prosenth@itsa.ucsf.edu; 
Melvin B Heyman - mheyman@peds.ucsf.edu; Denice Kong - KongD@surgery.ucsf.edu; Greg Magrane - gmagrane@c.ucsf.edu; Lee-Ann Baxter-
Lowe - baxterlowe@surgery.ucsf.edu; Marcus O Muench - muench@itsa.ucsf.edu
* Corresponding author    
Abstract
Background: Biliary atresia (BA) is a neonatal cholestatic disease of unknown etiology. It is the
leading cause of liver transplantation in children. Many similarities exist between BA and graft
versus host disease suggesting engraftment of maternal cells during gestation could result in
immune responses that lead to BA. The aim of this study was to determine the presence and extent
of maternal microchimerism (MM) in the livers of infants with BA.
Methods: Using fluorescent in situ hybridization (FISH), 11 male BA & 4 male neonatal hepatitis
(NH) livers, which served as controls, were analyzed for X and Y-chromosomes. To further
investigate MM in BA, 3 patients with BA, and their mothers, were HLA typed. Using
immunohistochemical stains, the BA livers were examined for MM. Four additional BA livers
underwent analysis by polymerase chain reaction (PCR) for evidence of MM.
Results: By FISH, 8 BA and 2 NH livers were interpretable. Seven of eight BA specimens showed
evidence of MM. The number of maternal cells ranged from 2–4 maternal cells per biopsy slide.
Neither NH specimen showed evidence of MM. In addition, immunohistochemical stains confirmed
evidence of MM. Using PCR, a range of 1–142 copies of maternal DNA per 25,000 copies of
patients DNA was found.
Conclusions: Maternal microchimerism is present in the livers of patients with BA and may
contribute to the pathogenesis of BA.
Background
Biliary atresia (BA) is a cholestatic disease of infancy char-
acterized by the destruction of the biliary tree. [1-3] Both
the intra-and extra-hepatic biliary ducts demonstrate evi-
dence of a progressive destruction. This results in cholesta-
sis, hepatic fibrosis and eventually cirrhosis. BA is
associated with significant morbidity and mortality.
Although the incidence of BA is 1 in 10,000 to 14,000 live
births, [4,5] it accounts for over 40% of the neonatal
cholestatic liver disease in Europe and the United States.
[6] Prior to the hepatic portoenterostomy and liver trans-
plantation, infants with BA had less than a 10% survival
Published: 31 July 2004
BMC Gastroenterology 2004, 4:14 doi:10.1186/1471-230X-4-14
Received: 06 May 2004
Accepted: 31 July 2004
This article is available from: http://www.biomedcentral.com/1471-230X/4/14
© 2004 Suskind et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Gastroenterology 2004, 4:14 http://www.biomedcentral.com/1471-230X/4/14at 3 years of life and almost 100% mortality at 7 years of
life. [7] In the United States, it is the leading cause of pedi-
atric liver transplantation. [8] The etiology of biliary
atresia remains unknown.
Many hypotheses on the etiology of BA exist. Two leading
hypothesis are that BA occurs as a result of ductal plate
malformations occurring during development of the liver,
or as a result of an immune mediated process triggered by
yet to be determined stimulus. [9] As more knowledge
accrues about the histology and immunologic characteris-
tics of BA, the more it appears to be a progressive immune
mediated process.
Graft versus host disease (GVHD), seen after allogeneic
hematopoietic stem cell transplantation, is an immune
mediated process triggered by the transfer of alloimmune
cells from a donor to a host. GVHD shares many similari-
ties with BA. Both BA and GVHD are characterized by a
lymphocytic infiltration around the portal triad and dam-
age to the biliary ducts. [10] The predominant lym-
phocytes in both disease are CD4+ T – helper (Th) 1 cells.
[11-14] As with BA, in GVHD there is also an increase in
cell adhesion molecules and human leukocyte antigen
(HLA) class II markers. [11]
Given the similarities between BA and GVHD, we hypoth-
esized that a contributing etiology of BA could be an
alloimmune reaction such as in GVHD triggered by mater-
nal microchimerism. Maternal microchimerism occurs
when a small number of maternal cells are transferred to
the offspring during pregnancy. This is known to occur in
up to 40% of normal pregnancies. [15,16] In addition, a
clinical precedent of maternal microchimerism causing
hepatic GVHD in children with severe combined immune
deficiency (SCID) exists. [17] The aim of this study was to
determine the presence and extent of maternal microchi-
merism in the livers of infants with BA.
Methods
This study was performed with the approval of the Com-
mittee of Human Research at USCF (H9048-20247-01).
Cases of BA were identified through a data search in the
Anatomic Pathology CoPath system by diagnosis or dur-
ing patient medical visits to the UCSF Division of Pediat-
ric Gastroenterology, Hepatology, and Nutrition. An
explanation of the study was given to each study candi-
date. Written consent was obtained from each study
participant.
Fluorescent in situ hybridization (FISH) of male BA livers
We modified a previously reported method of FISH, [18]
using X and Y-chromosomes probes. Y-chromosomes
were stained with a green fluorescent dye, fluorescein iso-
thiocyanate (FITC). X chromosomes were stained with a
red fluorescent dye, cyanine 3 (Cy-3). Nuclear material
was stained with a blue fluorescent dye 4", 6"-diamidino-
2-phenylindole (DAPI). After initial digestion and stain-
ing of the liver specimens, we examined the slides for evi-
dence of female cells, depicted by two red signals, i.e. X
chromosomes, with no green signal within the blue
nuclear material. Slides were analyzed in a blinded
fashion.
HLA typing
Patients with BA and their mothers were HLA typed. The
HLA typing HLA-A, -B, and -DRB1 alleles of the child and
mother were determined by sequence specific PCR (SSP)
(Pel-Freez Clinical Systems, LLC®, Brown Deer, WI, USA).
Immunohistochemistry
Frozen tissues sections of BA patient's livers (5 µm) were
fixed in acetone for 10 minutes at 4°C then washed in PBS
(5 minutes centrifugation × 3). Sections were blocked
with Protein Block (Dako, Carpinteria, CA, USA) for thirty
minutes at room temperature. Sections were then incu-
bated with anti-HLA-B14 mouse monoclonal antibody
(US Biological, Swampscott, Mass. USA) then washed in
PBS. Sections were incubated in goat anti-mouse conju-
gated with FITC for 30 minutes at room temperature. Sec-
tions were rewashed and then counterstained with DAPI.
Slides were then examined using a fluorescent
microscope.
Kinetic Polymerase Chain Reaction (kPCR)
Using the HLA types of the patients with BA and their
mothers, and a previously reported method of kPCR, evi-
dence of maternal DNA was explored within the liver
biopsy specimens of explanted BA livers. [18] The minor
modifications to the kinetic PCR protocol included use of
iCyler from BioRad (Hercules, Ca, USA) for amplification.
Results
Detection of female cells in male BA liver biopsies
Using FISH, we examined 11 male BA liver biopsies and 4
male NH liver biopsies. After initial digestion and staining
of the liver specimens, we were able to interpret 8 of the
BA and 2 NH liver biopsy specimens (Table 1). Three BA
and 2 NH biopsies underwent poor digestion and had no
discernable signal. Figure 1 shows a liver from a male
infant with BA. A male cell, depicted by a red signal, the X
chromosome, and green signal, a Y chromosome within
the blue nuclear material, clearly can be seen (A). In the
same specimen, one can also see a female cell, depicted by
two red signals, both X-chromosomes with no green sig-
nal within the blue nuclear material (B). 7/8 BA speci-
mens had evidence of maternal microchimerism. The
number of maternal cells, per biopsy slide, was 2 – 4 cells.
Neither of the NH specimens had evidence of maternal
microchimerism.Page 2 of 7
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samples
To further investigate our findings, three patients with BA
and their mothers were HLA typed. Using the HLA marker
B14, we examined the BA livers for evidence of maternal
microchimerism using immunohistochemistry tech-
niques. An HLA-B14 positive patient served as our posi-
tive control (Figure 2). Specimen B, our negative control,
was a patient who was, along with his mother, negative
for HLA-B14. Specimen C, our test specimen, was HLA-
B14-, with an HLA-B14+ mother. Specimen A (positive
control) has a bright signal for HLA-B14 while there is
only background staining for HLA-B14 in specimen B
(negative control). Specimen C, the test specimen, has iso-
lated scattered bright signals suggesting maternal
microchimerism.
Detection of maternal DNA by kPCR
Finally, using polymerase chain reaction, in conjunction
with the HLA typing of patients and mothers, we were
able to affirm that maternal microchimerism occurs in the
BA livers. An additional four fresh frozen liver specimens
of BA infants, obtained at the time of transplantation,
were examined for maternal DNA. All the livers had evi-
dence of maternal microchimerism, with the range of 1 to
142 copies of maternal DNA detected per 25000 copies of
patients' DNA. Figure 3 is a representative kPCR for mater-
nal HLA-B40 in the second liver sample.
In all eleven of twelve patients with BA had evidence of
maternal microchimerism by FISH or kinetic PCR, while
neither of the two neonatal hepatitis patients had evi-
dence of maternal microchimerism (p = 0.03).
Discussion
BA is a progressive cholestatic disease of infancy, which is
characterized by a mild to moderate lymphocytic infiltra-
tion within the extra and intrahepatic bile ducts. It is plau-
sible, that maternal microchimerism may play a role in
the etio-pathogenesis of BA by causing an alloimmune
reaction given the similarities between BA and GVHD. We
have shown that maternal microchimerism is present
within the livers of patients with BA.
Maternal microchimerism occurs when maternal cells
reside in the body of offspring. Maternal-fetal lym-
phocytic transfer is known to occur during pregnancy
starting as early as the tenth week of gestation and contin-
uing up to delivery. [19] The number of cells that traverse
the placenta increases throughout this period. Schroder et
al [15] demonstrated that approximately 1/10 infants has
about 0.07% maternal lymphocytes at the time of birth
and more recent findings by Lo et al. [16] have indicated
the presence of maternal cells in over 40% of fetal blood
samples.
Disease has been shown to occur in mothers who have
had fetal microchimerism, and children/adults who have
had maternal microchimerism. Children who have
Table 1: Overview of maternal microchimerism in patients with BA and NH
Diagnosis Chimerism Method # of Maternal cells/DNA per slide (FISH) or per 25,000 copies of 
patient's DNA (kPCR)
BA Present FISH 2 maternal cells per slide
BA Present FISH 2 maternal cells per slide
BA Present FISH 4 maternal cells per slide
BA Present FISH 2 maternal cells per slide
BA Present FISH+immunokistochemistry 3 maternal cells per slide
BA Not interpretable FISH ---
BA Present FISH 2 maternal cells per slide
BA Present FISH 3 maternal cells per slide
BA Not interpretable FISH ---
BA Not interpretable FISH ---
BA None detected FISH 0 maternal cells per slide
BA Present kPCR 3 copies of maternal DNA per 25,000 copies of patient's DNA
BA Present kPCR 1 copy of maternal DNA per 25,000 copies of patient's DNA
BA Present kPCR 10 copies of maternal DNA per 25,000 copies of patient's DNA
BA Present kPCR 142 copies of maternal DNA per 25,000 copies of patient's DNA
NH None detected FISH 0 maternal cells per slide
NH None detected FISH 0 maternal cells per slide
NH Not interpretable FISH ---
NH Not interpretable FISH ---Page 3 of 7
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disease owing to engraftment of maternal lymphocytes. In
both SCID and DiGeorge syndrome, maternal microchi-
merism and GVHD have been well described. In a study
by Susanne Müller et al., 121 patients with SCID were
evaluated for maternal microchimerism using HLA typ-
ing. Maternal cells were found in 48 patients, with 19
patients showing signs of GVHD. GVHD manifested itself
in the skin and in the liver. [20] There have been numer-
ous case reports showing GVHD in infancy of patients
with DiGeorge. Manifestations of this disease include
skin, gastrointestinal tract and liver involvement. [21]
The histologic and immunologic similarities of BA and
GVHD are striking. The site of damage in BA and GVHD
after bone marrow transplantation is the same. In each,
lymphocytes congregate around the bile ducts. The dam-
age occurs to both the intra-and extrahepatic biliary tracts.
In a mouse model of acute GVHD, Nonomura et al.
showed that transfer of allogeneic cells set along minor
HLA mismatch can cause damage to both the intra and
extrahepatic biliary ducts. Interestingly, the timeframe in
this mouse model of acute GVHD, in terms of lym-
phocytic infiltration and fibrosis, appear similar to that of
BA. [14] Initially, a peak of lymphocytes around the bile
ducts occurs about 2 weeks after transfer of allogeneic cells
from donor to host mouse; as the lymphocytic infiltration
subsides, liver fibrosis increases. This correlates with dis-
ease progression in BA, where initial diagnostic biopsies
of BA livers usually show a larger lymphocytic infiltration,
and less fibrosis, as compared to biopsies done later, i.e.
at the time of liver transplantation. [22]
The lymphocytic infiltrates in both BA and GVHD are pre-
dominantly CD4+ T lymphocytes. The genes in BA livers
showed differential lymphocytic function, with activation
of osteopontin, a regulator of cell-mediated immunity in
Th 1 cells, and interferon gamma. [23] Similarly, in
GVHD, the predominant leukocyte is the CD4+ T lym-
phocyte. Although a variety of complex mechanisms are
involved in causing the end organ damage in GVHD, evi-
dence exists showing similarities in effector mechanisms.
A male cell, depicted by a red signal, the X chromosome, and green signal, a Y chromosome within the blue nuclear material, can be seen in bo h male BA liver specimens (A&B)Figur  1
A male cell, depicted by a red signal, the X chromosome, and green signal, a Y chromosome within the blue nuclear material, 
can be seen in both male BA liver specimens (A&B). In the same specimen, one can also see a female cell, depicted by two red 
signals, both X-chromosomes with no green signal within the blue nuclear material (arrow).Page 4 of 7
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interferon-gamma secretion with a synchronized increase
in activated Th cells was seen during acute GVHD. [24]
The inflammatory responses in both BA and GVHD are
also associated with increased expression of adhesion
molecules such as CD54, and increased class II HLA mark-
ers, such as HLA-DR. HLA-DR and CD54, in both BA and
GVHD, are seen predominantly around the bile ducts.
[11,25,26]
Maternal microchimerism is not a rare occurrence in
healthy individuals, but is usually not associated with dis-
ease. The high occurrence of maternal microchimerism in
healthy individuals has been suggested to have a toler-
genic effect that may contribute to long-term
microchimerism. [27]Additionally, in utero transplanta-
tion of haploidentical cells does not always lead to
immune tolerance [28] and may lead to immune sensiti-
zation. Thus, the immunological consequences of the
migration of maternal cells to the fetus appear to be vari-
able. In most cases the maternal cells are likely to be
cleared by the host's immune system or they may escape
destruction by the immune system leading to engraft-
ment. Engraftment of maternal immune cells in the fetal
Using the HLA marker B14, we examined the BA livers for evidence of maternal microchimerism using immunohistochemistry techniqu sFigure 2
Using the HLA marker B14, we examined the BA livers for evidence of maternal microchimerism using immunohistochemistry 
techniques. An HLA-B14 positive patient served as our positive control (A). Specimen B, our negative control, was a patient 
who was, along with his mother, negative for HLA-B14. Specimen C, our test specimen, was HLA-B14 negative, with an HLA-
B14+ mother. Specimen A (positive control) has a bright signal for HLA-B14 while there is only background staining for HLA-
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host cholangiocytes. This is what we believe may occur in
infants with BA. Alternatively, engrafted maternal cells in
the fetus may subsequently be rejected by the immune
system of the offspring, leading to destruction of the bil-
iary tree.
Maternal microchimerism occurs in the livers of patients
with BA. Given the previously well-described relationship
between microchimerism and GVHD, and the similarities
between BA and GVHD, these findings indicate a poten-
tial etio-pathogenisis for BA. Further investigations into
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